We are Praxis Precision Medicines. We are a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for patients affected by central nervous system (CNS) disorders characterized by neuronal imbalance, including patients and families impacted by rare genetic epilepsies. We are a group of neurologists, geneticists, scientists, and parents of children with SCN2A mutations. And like all parents, we are fighting to give our children – and all children with brain disorders – the most fulfilling existence we can.

We invite you to join us as we progress exciting new potential treatments through clinical development and team with our allies in the fight against this devastating disorder.

Program updates will be provided as new information is available about clinical trials, education, and resources to support the SCN2A community.